ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,670, issued on Aug. 19, was assigned to LEADXPRO AG (Villigen, Switzerland).
"Functionalized aminotriazines" was invented by Werner Neidhart (Villigen, Switzerland) and Denis Bucher (Villigen, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel antagonists of the A2B adenosine receptor and pharmaceutical compositions comprising said antagonists as well as their uses for the treatment and prevention of disorders known to be susceptible to improvement by antagonism of the A2B receptor such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary fibrosis, vascular diseases, allergic diseases, hy...